Dual Targeting of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase and Histone Deacetylase as a Therapy for Colorectal Cancer

Statins are 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase (HMGR) inhibitors decreasing serum cholesterol and have shown promise in cancer prevention. In this study, we demonstrated the oncogenic role of HMGR in colorectal cancer (CRC) by disclosing increased HMGR activity in CRC patients...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Tzu-Tang Wei, Yi-Ting Lin, Wen-Shu Chen, Ping Luo, Yu-Chin Lin, Chia-Tung Shun, Yi-Hsin Lin, Jhih-Bin Chen, Nai-Wei Chen, Jim-Min Fang, Ming-Shiang Wu, Kai-Chien Yang, Li-Chun Chang, Kang-Yu Tai, Jin-Tung Liang, Ching-Chow Chen
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Elsevier 2016-08-01
Sarja:	EBioMedicine
Aiheet:	Colorectal cancer HMG-CoA reductase Histone deacetylase Statin hydroxamate Preclinical model
Linkit:	http://www.sciencedirect.com/science/article/pii/S2352396416303243
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!